Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD) Article

Chaiworapongsa, Tinnakorn, Romero, Roberto, Korzeniewski, Steven J et al. (2016). Pravastatin to prevent recurrent fetal death in massive perivillous fibrin deposition of the placenta (MPFD) . Journal of Maternal-Fetal and Neonatal Medicine, 29(6), 855-862. 10.3109/14767058.2015.1022864

Open Access International Collaboration

cited authors

  • Chaiworapongsa, Tinnakorn; Romero, Roberto; Korzeniewski, Steven J; Chaemsaithong, Piya; Hernandez-Andrade, Edgar; Segars, James H; DeCherney, Alan H; McCoy, M Cathleen; Kim, Chong Jai; Yeo, Lami; Hassan, Sonia S

sustainable development goals

authors

publication date

  • March 18, 2016

published in

keywords

  • ANTI-ANGIOGENIC FACTORS
  • ANTIANGIOGENIC FACTORS
  • ANTIPHOSPHOLIPID ANTIBODIES
  • Angiogenic factors
  • CHRONIC CHORIOAMNIONITIS
  • EARLY-PREGNANCY
  • FACTOR RECEPTOR-1 CONCENTRATION
  • GROWTH-FACTOR
  • INTRAVENOUS IMMUNOGLOBULIN
  • Life Sciences & Biomedicine
  • MATERNAL FLOOR INFARCTION
  • Obstetrics & Gynecology
  • SOLUBLE ENDOGLIN
  • Science & Technology
  • maternal floor infarction
  • placental growth factor
  • preeclampsia
  • proton pump inhibitor
  • soluble endoglin
  • soluble vascular endothelial growth factor receptor-1

Digital Object Identifier (DOI)

start page

  • 855

end page

  • 862

volume

  • 29

issue

  • 6